E3A Healthcare at BIOHK2023: Broadening Our Global Footprint

On September 13th, BIOHK2023 kicked off in the presence of Mr. Leung Chun-ying, Vice-Chairman of the National Committee of the Chinese People's Political Consultative Conference (CPPCC) and the third Chief Executive of the Hong Kong Special Administrative Region (HKSAR), Mr. Bruce Beutler, winner of the Nobel Prize for Physiology or Medicine 2011, Prof. Han Jisheng of the Chinese Academy of Sciences, and Prof. Yu Changhai, Chairman of BIOHK2023, as well as a number of governmental representatives and authoritative experts.

BIOHK is one of the largest international biotechnology convention and exhibition center in Asia. The event encompassed industries such as healthy longevity and aging, clinical nutrition and wellness, policy support for life science ecology in the Greater Bay Area, and cancer research and drug development. It also included Chinese biopharmaceutical enterprises going overseas and the development of traditional Chinese medicine, etc.

This time, E3A Healthcare participated in BIOHK2023 to meet with industry experts, entrepreneurs, and decision makers from all over the world. In addition to the opportunity to showcase our innovative medical products and solutions, it is also an ideal place to network with peers, share insights, and explore the global biotech frontier.

Our presence at BIOHK2023 is threefold. First, we're looking to expand our global network. Connecting with biotech experts and innovators, building partnerships, and keeping our finger on the pulse of the industry are key priorities.

Second, we're using this platform to raise E3A Healthcare's international profile. We want to get our innovative products and solutions in front of a wider audience and share our commitment to improving the health of women and newborns.

Finally, we're excited to swap ideas with industry leaders. This exchange will boost our innovation capabilities and help us contribute even more effectively to women's and newborn health solutions.

BIOHK2023 Hong Kong International Biotechnology Convention & Exhibition is an event that brings together the power of global biotechnology innovation. E3A Healthcare will make full use of this platform to help our mission, as well as contribute to the future of the industry. We are eagerly looking forward to meeting you, discussing the road of innovation and shaping a “healthier” future together.

Previous
Previous

E3A Healthcare: Slush Shanghai 2023, Exploring the Future of Medical Technology

Next
Next

E3A Healthcare wins the 2nd prize at HKUST’s International Entrepreneurship Competition!